AstraZeneca's Lung-Cancer Drug Gets EU Approval
By Sabela Ojea AstraZeneca PLC said Friday that its Tagrisso drug has been approved in the European Union to treat early stages of lung cancer. The pharmaceutical company said the results... | May 28, 2021
Source: marketscreener.com